PARTNERS & SUPPORT

Advancing innovation through collaboration

At Imuno Therapeutics, breakthrough innovation is built through collaboration. We work closely with academic institutions, healthcare partners, technology providers, and public innovation programmes to accelerate the development of next-generation immunotherapies. These collaborations provide access to scientific expertise, advanced technologies, and translational research capabilities that help us move novel discoveries towards therapies for patients.

Scientific & Technology Partners

Developing first-in-class therapeutics requires expertise across multiple disciplines. We collaborate with leading partners in immunology, protein engineering, computational biology, analytical sciences and translational research.

Together, we are building technologies that enable the discovery of highly selective therapeutics against previously inaccessible intracellular disease targets.

Research & Innovation Support

Innovation in biotechnology requires long-term investment. Imuno Therapeutics is grateful for the support of regional, national and European innovation programmes that stimulate scientific excellence, technology development and economic growth.

Their support enables us to accelerate platform development, strengthen collaborations and translate innovative research into future therapies.

Kansen voor West (European Regional Development Fund)

Imuno Therapeutics participates in the STRIPE project, which is supported through the Kansen voor West programme and co-funded by the European Regional Development Fund (ERDF).

The STRIPE project focuses on the development of innovative technologies that advance precision immunotherapy through collaboration between biotechnology companies and academic partners. Within this programme, Imuno Therapeutics is developing next-generation discovery technologies for highly specific peptide antibodies to address unmet medical needs in cancer and immune-mediated diseases.

We gratefully acknowledge the support provided through this programme.